AstraZeneca PLC
AstraZeneca Stock Slides as FDA Panel Rejects New Cancer Drug Proposal: What Does This Mean for Investors?
Shares of AstraZeneca dipped on Friday after U.S. regulators recommended against its new cancer drug. The FDA advisory committee voted ... Read more
Stay Ahead of the Market: S&P 500 Futures Steady as Wall Street Anticipates ‘Mag 7’ Earnings and Fed Decision – Live Updates!
Traders are keeping a close eye on the markets as they await important earnings reports from major companies and the ... Read more
Trump Announces Game-Changing Plan to Lower Costs and Expand Coverage for Obesity Treatments
Recently, President Donald Trump announced a new deal with drugmakers Eli Lilly and Novo Nordisk. This plan aims to make ... Read more
Trump Unveils Game-Changing Deals with Eli Lilly and Novo Nordisk: Reduced Prices on Weight Loss Drugs and Enhanced Medicare Coverage!
President Donald Trump recently made headlines by announcing new agreements with Eli Lilly and Novo Nordisk. These deals aim to ... Read more
Trump’s Pharmaceutical Tariff Threat Dims as Pfizer Deal Reassures Drugmakers: What It Means for the Industry
On September 30, 2025, President Donald Trump made headlines by shaking hands with Pfizer’s CEO, Albert Bourla, to announce a ... Read more
Trump’s New Import Taxes: What You Need to Know About Rising Prices on Pharmaceuticals, Furniture, and Heavy Trucks
President Announces Major Tariffs on Imports President Donald Trump revealed he plans to impose hefty import taxes on various products ... Read more
FDA Targets Hims & Hers: What You Need to Know About New Weight Loss Drug Advertising
Federal health officials are now focusing on telehealth companies that promote unofficial versions of prescription drugs, especially popular weight loss ... Read more
Why Eli Lilly’s Obesity Pill Is Still a Strong Contender Against Novo’s Wegovy Despite Mixed Investor Reactions
Eli Lilly’s stock has been on a rollercoaster ride recently. It took a hit after the company released data on ... Read more
